Nova Molecular Inc., SignalGene deal

SGI withdrew its offer to purchase pharmacogenomics company Nova Molecular for 3.4 million SGI shares, valued at C$6.9 million (US$4.6 million) (see BioCentury, Aug. 28). SGI said it concluded that me...